Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

DOI Full Paper Access

106

Citations

13

References

2013

Year

Jubilee Brown, William E. Brady, Julian C. Schink, Linda Van Le, Mario M. Leitão, S. Diane Yamada, Koen De Geest, David M. Gershenson

Abstract

Bevacizumab has activity in the treatment of recurrent sex cord-stromal tumors of the ovary, and its toxicity is acceptable. Further investigation is warranted.

References

	Year	Citations

Page 1